Nancy Wenjia Yu, Senior Director of Business Development at Danaher Diagnostics, drives strategy for a $10B platform, impacting Beckman Dx & Cepheid. Ex-BCG, she brings 8 years of expertise in MedTech, LST & Dx across US, EU, China & Japan. A Stanford MBA, Nancy transforms healthcare innovations into tangible global impact, nominated for her leadership in enterprise strategy and cross-market solutions.
666 3rd Ave, 6th Floor, New York, NY 10017